SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-21-145438
Filing Date
2021-04-30
Accepted
2021-04-30 17:01:27
Documents
16
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d28428d10ka.htm   iXBRL 10-K/A 702048
2 EX-31.3 d28428dex313.htm EX-31.3 3615
3 EX-31.4 d28428dex314.htm EX-31.4 3629
  Complete submission text file 0001193125-21-145438.txt   975535

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA gwph-20201231.xsd EX-101.SCH 5070
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gwph-20201231_cal.xml EX-101.CAL 754
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gwph-20201231_def.xml EX-101.DEF 1759
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE gwph-20201231_lab.xml EX-101.LAB 28062
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gwph-20201231_pre.xml EX-101.PRE 17382
9 EXTRACTED XBRL INSTANCE DOCUMENT d28428d10ka_htm.xml XML 8456
Mailing Address SOVEREIGN HOUSE VISION PARK HISTON, CAMBRIDGE CB24 9BZ X0 00000
Business Address SOVEREIGN HOUSE VISION PARK HISTON, CAMBRIDGE CB24 9BZ X0 00000 44 1223 266800
GW PHARMACEUTICALS PLC (Filer) CIK: 0001351288 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-35892 | Film No.: 21879335
SIC: 2834 Pharmaceutical Preparations